| __timestamp | Apellis Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2908166 | 2999000 |
| Thursday, January 1, 2015 | 6356782 | 10393000 |
| Friday, January 1, 2016 | 4303743 | 15994000 |
| Sunday, January 1, 2017 | 10463151 | 26975000 |
| Monday, January 1, 2018 | 22639184 | 39509000 |
| Tuesday, January 1, 2019 | 67046483 | 48869000 |
| Wednesday, January 1, 2020 | 139401000 | 42510000 |
| Friday, January 1, 2021 | 176771000 | 46105000 |
| Saturday, January 1, 2022 | 277163000 | 50513000 |
| Sunday, January 1, 2023 | 500815000 | 51292000 |
Unleashing insights
In the competitive world of biotechnology, managing expenses is crucial for success. This chart offers a fascinating glimpse into the Selling, General, and Administrative (SG&A) expenses of Apellis Pharmaceuticals, Inc. and Wave Life Sciences Ltd. from 2014 to 2023.
Apellis Pharmaceuticals has seen a dramatic increase in SG&A expenses, skyrocketing from approximately $3 million in 2014 to over $500 million in 2023. This represents a staggering growth of over 16,000%, reflecting the company's aggressive expansion and investment in administrative capabilities.
In contrast, Wave Life Sciences Ltd. has maintained a more conservative growth in SG&A expenses, increasing from around $3 million in 2014 to just over $51 million in 2023, a growth of approximately 1,600%. This steady rise suggests a more measured approach to scaling operations.
These trends highlight the differing strategies of these two biotech firms in managing their operational costs.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: argenx SE vs Apellis Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Apellis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Evotec SE
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights